When compared as indicated above, significantly increased HLA-DQ fold differences were revealed in CD11c+ MoDCs originating from CeD patients versus CTL when levels were relatively compared against a normalised LPS background (2.2-fold increase, p = 0.0179; Figure 3C right). This evidence concerns the gene ITGAX and cranioectodermal dysplasia.